Intervention Review

You have free access to this content

Artemether-lumefantrine (six-dose regimen) for treating uncomplicated falciparum malaria

  1. Aika AA Omari1,*,
  2. Carrol L Gamble2,
  3. Paul Garner3

Editorial Group: Cochrane Infectious Diseases Group

Published Online: 21 JAN 2009

Assessed as up-to-date: 17 AUG 2005

DOI: 10.1002/14651858.CD005564

Database Title

Additional Information

How to Cite

Omari AAA, Gamble CL, Garner P. Artemether-lumefantrine (six-dose regimen) for treating uncomplicated falciparum malaria. Cochrane Database of Systematic Reviews 2005, Issue 4. Art. No.: CD005564. DOI: 10.1002/14651858.CD005564.

Author Information

  1. 1

    Alder Hey Children's Hospital, Liverpool, UK

  2. 2

    University of Liverpool, Centre for Medical Statistics and Health Evaluation, Liverpool, UK

  3. 3

    Liverpool School of Tropical Medicine, International Health Group, Liverpool, Merseyside, UK

*Aika AA Omari, Alder Hey Children's Hospital, Eaton Road, Liverpool, L12 2AP, UK. aomari@nhs.net. aika@omari1677.freeserve.co.uk.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 21 JAN 2009

SEARCH

ARTICLE TOOLS

View Full Article (HTML) Summary (59K)Standard (297K)Full (456K)
[Analysis 1.1]
Analysis 1.1. Comparison 1 Artemether-lumefantrine vs amodiaquine, Outcome 1 Total failure by day 28.
[Analysis 1.2]
Analysis 1.2. Comparison 1 Artemether-lumefantrine vs amodiaquine, Outcome 2 Total failure by day 14.
[Analysis 1.3]
Analysis 1.3. Comparison 1 Artemether-lumefantrine vs amodiaquine, Outcome 3 Gametocyte carriage on day 14.
[Analysis 2.1]
Analysis 2.1. Comparison 2 Artemether-lumefantrine vs chloroquine plus sulfadoxine-pyrimethamine, Outcome 1 Total failure by day 28.
[Analysis 2.2]
Analysis 2.2. Comparison 2 Artemether-lumefantrine vs chloroquine plus sulfadoxine-pyrimethamine, Outcome 2 Total failure by days 42, 14, and 7.
[Analysis 2.3]
Analysis 2.3. Comparison 2 Artemether-lumefantrine vs chloroquine plus sulfadoxine-pyrimethamine, Outcome 3 Gametocyte carriage on days 28, 14, and 7.
[Analysis 3.1]
Analysis 3.1. Comparison 3 Artemether-lumefantrine vs amodiaquine plus sulfadoxine-pyrimethamine, Outcome 1 Total failure by day 28.
[Analysis 3.2]
Analysis 3.2. Comparison 3 Artemether-lumefantrine vs amodiaquine plus sulfadoxine-pyrimethamine, Outcome 2 Total failure by day 14.
[Analysis 3.3]
Analysis 3.3. Comparison 3 Artemether-lumefantrine vs amodiaquine plus sulfadoxine-pyrimethamine, Outcome 3 Gametocyte carriage on day 14.
[Analysis 4.1]
Analysis 4.1. Comparison 4 Artemether-lumefantrine vs amodiaquine plus artesunate, Outcome 1 Total failure by day 28.
[Analysis 4.2]
Analysis 4.2. Comparison 4 Artemether-lumefantrine vs amodiaquine plus artesunate, Outcome 2 Total failure by day 14.
[Analysis 4.3]
Analysis 4.3. Comparison 4 Artemether-lumefantrine vs amodiaquine plus artesunate, Outcome 3 Gametocyte carriage on days 14 and 7.
[Analysis 5.1]
Analysis 5.1. Comparison 5 Artemether-lumefantrine vs mefloquine plus artesunate, Outcome 1 Total failure by day 28.
[Analysis 5.2]
Analysis 5.2. Comparison 5 Artemether-lumefantrine vs mefloquine plus artesunate, Outcome 2 Total failure by day 28: PCR adjusted.
[Analysis 5.3]
Analysis 5.3. Comparison 5 Artemether-lumefantrine vs mefloquine plus artesunate, Outcome 3 Total failure by day 42.
[Analysis 5.4]
Analysis 5.4. Comparison 5 Artemether-lumefantrine vs mefloquine plus artesunate, Outcome 4 Total failure by day 42: PCR adjusted.
[Analysis 5.5]
Analysis 5.5. Comparison 5 Artemether-lumefantrine vs mefloquine plus artesunate, Outcome 5 Gametocyte carriage on day 7 and in first 72 h.
[Analysis 6.1]
Analysis 6.1. Comparison 6 Artemether-lumefantrine vs dihydroartemisinin-napthoquine-trimethoprim (DNP), Outcome 1 Total failure by day 28.
[Analysis 7.1]
Analysis 7.1. Comparison 7 Artemether-lumefantrine: supervised vs unsupervised treatment, Outcome 1 Total failure by day 28.
View Full Article (HTML) Summary (59K)Standard (297K)Full (456K)